Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]

✍ Scribed by De, Pradip; Sun, Yuling; Carlson, Jennifer H.; Friedman, Lori S.; Leyland-Jones, Brian R.; Dey, Nandini

• Book ID: 124116875
• Publisher: Neoplasia Press
• Year: 2014
• Tongue: English
• Weight: 261 KB
• Volume: 16
• Category: Article
• ISSN: 1522-8002
• DOI: 10.1016/j.neo.2014.03.012